Chikungunya Alert: Costa Rica
Current Situation
The CDC has issued a Level 2 travel alert regarding an ongoing chikungunya outbreak in Guanacaste Province, Costa Rica. The majority of confirmed cases have been concentrated in the Playa Langosta area. This alert advises travelers to take precautions while visiting the affected region.
About Chikungunya
Chikungunya is a viral infection transmitted primarily through the bite of infected Aedes mosquitoes (the same vectors responsible for dengue and Zika). The disease is characterized by:
- Sudden onset of fever and severe joint pain (particularly in hands, feet, and knees)
- Rash, headache, and muscle pain
- Symptoms typically appearing 3–7 days after infection
- Joint pain that can persist for weeks or months in some individuals
While chikungunya is rarely fatal, the prolonged arthralgia can significantly impact quality of life during and after travel.
Preventive Measures
Travelers to Guanacaste Province should prioritize mosquito-bite prevention:
- Use EPA-registered insect repellents (containing DEET, picaridin, or oil of lemon eucalyptus)
- Wear long-sleeved clothing and long pants, especially during dawn and dusk when mosquitoes are most active
- Stay in air-conditioned or screened accommodations
- Consider treating clothing with permethrin
- Avoid areas with standing water where mosquitoes breed
Travel Recommendations
A Level 2 alert suggests that travel is generally safe with normal precautions. However, travelers should:
- Be aware of local conditions and monitor official CDC updates
- Consult with a travel health provider before departure, particularly those with chronic conditions or compromised immunity
- Seek medical evaluation promptly if fever and joint pain develop during or after travel
- Report symptoms to healthcare providers and mention recent travel history
Pharmacist's Note: While no vaccine currently exists for chikungunya, vaccination status for other travel-related illnesses (yellow fever, typhoid, hepatitis A/B) should be verified. Travelers should carry appropriate pain management supplies, as over-the-counter analgesics may be limited or different brands may be available locally. Consult your pharmacist about your travel health kit before departure, and ensure any chronic medications are adequately stocked. Upon return, if symptoms develop within two weeks, inform healthcare providers of potential chikungunya exposure to facilitate appropriate testing and management.
Reference
For updates and additional information, visit the CDC Travel Health Notices page regularly.